A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA)
Journal article published in 2019 by
Nadja M. Meindl-Beinker 
,
Johannes Betge,
Tobias Gutting,
Elke Burgermeister,
Sebastian Belle,
Tianzuo Zhan,
Nadine Schulte,
Martin Maenz,
Matthias P. Ebert,
Nicolai Haertel
,
Johannes Betge,
Tobias Gutting,
Elke Burgermeister,
Sebastian Belle,
Tianzuo Zhan,
Nadine Schulte,
Martin Maenz,
Matthias P. Ebert,
Nicolai Haertel
This paper is made freely available by the publisher.
Full text: Download
Data provided by 